InvestorsHub Logo
Followers 16
Posts 1063
Boards Moderated 0
Alias Born 09/01/2019

Re: None

Friday, 10/30/2020 12:16:31 PM

Friday, October 30, 2020 12:16:31 PM

Post# of 16706
The important phrase I see is...
"the external Data and Safety Monitoring Board (“DSMB”) has once again unanimously approved the continuation of the Company’s multinational Phase 2b/3 human study of NP-120 (Ifenprodil) for the treatment of COVID-19."

"AGAIN UNANIMOUSLY APPROVED"